9/3/2021Arctic Vision Obtains China IND Clearance for PIII Study of ARVN003, F...

9/3/2021Inventiveness of Chinese Second Medical Use Patent: A Study From Top 1...

9/3/2021Wyeth Secured Win With Punitive Damages But Courts Had Different Opini...

9/3/2021Investment Prospects in China's Biopharmaceuticals and Biomaterials In...

9/3/2021Healthcare Sector Could Be the Next Target of Chinese Regulatory Crack...

9/1/2021What Are China's Pharma Prospects as the Country Enters Another New No...

9/1/2021NMPA Announces Package Insert Revision of Creatine Phosphate Sodium fo...

9/1/2021CDE Seeks Comments on Implementation Advice on ICH Guidelines E18, M3(...

9/1/2021CDE Solicits Comments on the Technical Guidance on Clinical Protocol f...

9/1/2021Junshi Bio and Coherus Completes Rolling BLA Submission of Toripalimab...

9/1/2021CStone Files Chinese NDA of Sugemalimab for Stage III NSCLC

9/1/2021U.S. FDA Apprves BeiGene's BRUKINSA (Zanubrutinib) for Waldenström's ...

9/1/2021Harbour BioMed Gets Chinese IND Approval for PII Trial of Anti-FcRn Ba...

8/31/2021Insilico and 4B Tech Tie Up to Advance Drug Discovery for Neurodegener...

8/31/2021NHSA Issues the Notice on the Public Service Item List of Centralized ...

8/31/2021Financial-related Company News in Brief (August 2021)

8/31/2021Eight Central Government Agencies Issues the Pilot Plan for Deepening ...

8/31/2021Jingxin In-licenses Epilepsy Drug from Bio-Pharm Solutions for $40M

8/31/2021HUYABIO Files an IND with the FDA for the Novel SHP2 Inhibitor HBI-237...

8/31/2021InnoCare Pharma to Launch US Trial of ICP-723 for NTRK Fusion-Positive...

8/30/2021NMPA Issues the Notice on Deepening Certification and Licensing Separa...

8/30/2021CDE Solicits Comments on the Technical Guidance on Clinical Pharmacolo...

8/30/2021Ligand's Partner Gloria Bio Wins Chinese Approval for Zimberelimab

8/30/2021Judges Send GSK Corporate Drama to Court in Philadelphia

8/30/2021China Misses Target on Approval of Biontech-Pfizer Shot, Raising Quest...

8/30/2021Winners and Losers in China's Sweeping Private-Sector Crackdown

8/29/2021NHSA Concludes the List of Drugs Passing Form Evaluation for Inclusion...

8/29/2021CDE Solicits Comments on the Technical Guidance for Non-Clinical Drug ...

8/29/2021CDE Solicits Comments on the Procedures and Requirements for Filing Po...

8/27/2021Junshi Bio Granted Chinese IND Approval for Subcutaneous Injection of ...

Page:171/774 Total number of articles:23207: [First][<<] [169] [170] [171] [172] [173] [>>] [End]